Table 2 Study assessment schedules

Consent and randomise

x

Contact details

x

f,e

a

Living circumstances

x

f

x

e

x

x

Training (physio, etc.)

e

e

e

1⁰ Outcome-smRSq (mRS) [26, 31–33]

a

a

x

x

Depression diagnosis

x

f,e

a

x

x

x

PHQ2 [56]

f,e

PHQ9 [43]

a

a

a

a

MHI 5 [37–39]

f,e

f,e

MADRS [40, 41]

e

e

e

Emotionalism

e

DSM IV for depression [42]

e

e

e

e

SIS [34–36]

x

x

Fatigue subscale SF36 [44, 45]

x

e

x

x

Cognition (TICSm) [46]

a

a

Cognition (MoCA) [47]

e

e

EQ5D-5 L [48]

e

e

x

x

EQD thermometer

a

a

SF12 [59]

a

Adverse events

f,e

e

a,e

e

x

x

Adherence to IMP

f

e

a,e

e

x

All medications

x

f

a

x

a

Retrieve residual capsules (pill count)

e

x

Physical therapy received

e

e

Resource use over 12 months

x